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The difficulties of therapeutic choice in patients with broncho-obstructive states are due to 
complex pathogenesis of disease as well as to prevalence of one or another pathogenetic mecha­
nism during single stages of its evolution (atopia, infectious-allergic component, dysbalance of 
bronchial autonomic regulation, glucocorticosteroid deficit, etc.). Recently, no new in principle 
discoveries in the field of bronchial obstruction treatment have occurred, indeed. However, pre­
vious solutions are optimized to a considerable extent ( 1 , 2, 5). Indications and schedules for 
application of bronchoselective β2-adrenergic agonists for inhalatory, peroral and parenteral 
use, anticholinergic medicaments, inhibitors of mediator release, corticosteroids for local appli­
cation are already specified. Medicamentous forms of theophyllin derivatives are improved. Des­
pite of undoubted successes achieved in mastering of reversible bronchial obstruction it pres­
ents a serious therapeutic problem in single cases and at different stages till now. Besides mod-
dern bronchorelaxing means are not free of side effects. That is why renewal of our therapeutic 
possibilities has a definite practical importance (3 ,4 , 8, 9). 
The purpose of the present communication is to evaluate comparatively the clinical effecti­
veness of some contemporary therapeutic schemes of bronchoobstructive diseases. 
Material and Methods 
During the period 1980-1986 a total of 195 bronchial obstruction patients (i.e. with in­
fectious-allergic form of bronchial asthma and chronic obstructive bronchoobstructive disease) 
were followed-up in the Clinic of Pulmology and ambulatorily (in the allergological and poly-
clinical consulting rooms of Hospital, Varna). Varna). Patients with approximately equally ex­
pressed bronchial obstruction evaluated according to physical and spirographs examination 
were selected. Patients were divided into 7 groups as followed: 1st _ 30 patients treated with 
prolonged xanthine preparations (Phyllocontin or Bulgarian ̂ preparation "Theotard") at dosage 
of 300 mg twice daily; 2nd _ 30 patients treated withNovphyllin at dosages 200 mg thrice dai­
ly-3rd _ 30 patients treated with selective fc2 -agonists; Salbutamol or Partusisten (Fenoterol); 
4th _ 30 patients treated with cholinoly tic preparation — Atrovent for inhalatory use at dosage 
of 0.2 mg thrice daily; 5th - 30 patients treated with inhalatory corticosteroid preparation -
Beclomethasondipropionat (Beclomet) at dosage of 100 mg 4 times daily; 6th - 15 patients 
treated with calcium agonist — Isoptin in an acute experiment used in patients with contra­
indications to xanthine preparations and fc-agonists, and 7th _ 30 patients treated with soidum 
chromoglycate (Intal) at dosage of 20 mg four times daily or with Ketodiphen (Zaditen) at 
dosage of 1 mg twice daily. Patients were followed-up for three months. At the beginning of 
treatment as well as at the end of every month a functional examination of respiration was car­
ried out by using of 'Tneumoscreen" apparatus and alveolo-diffusion test of the firm "Jaeger". 
Therapeutic effect was evaluated according to clinical and spirographs criteria. Presence of fa­
vourable effect was considered when paroxysmal bronchial obstruction disappeared or at least 
reduced, accompanying cough arid physically manifested bronchial spasm decreased and spiro-
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graphic parameters, especially F E V ! , increased by more than 15 per cent. Data obtained were 
processed by the methods of non-parametric and variation analyses. 
Results and Discussion 
The results from our study are shown on table 1.. 
Monotherapy with xanthine derivatives - a rapidly acting and prolonged theophyllin prepa­
rations influences favourably upon more than the half of the patients. However, patients with 
good therapeutic effect prevail. Significant side unfavourable phenomena during the therapeutic 
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course are not observed. However, patients' majority (53.3 per cent) showed an exacerbation 
(bronchial spasm) during the 3-month long follow-up. The relative share of favourably influen-
ed patients after Salbutamol therapy is approximately equal to that of patients after theophyl­
lin preparation therapy when the group of selective fi2-agonists is concerned. However, side 
unfavourable effects are noted in 24.3 per cent of the cases predominantly of the cardiovascular 
system. Partusisten (Fenoterol) eliminates bronchospasm still on the 3 0 ш min. This favourable 
effect as well as the increase of spirograpliic values retain for hours. Sinus tachycardia is observ­
ed and electrocardiographically registered in 14 of all the 15 patients causing therapy cessation 
in 5 of them. Headache is found in two patients but tremor accompanying tachycardia in three 
ones. The relative share of favourably influenced patients after Atrovent therapy is high (63.3 
per cent) although spirographs indexes do not undergo such a favourable dynamics, too, when 
compared with those of patients from the other groups. Immediately after AtrovenJ inhalation, 
tachycardia is registered with 5 patients. It disappeared spontaneously one hour after the pro­
cedure. 
In patients of the 6 Ш group Isoptin therapy results in favourable influence and spirographs 
value increase 30 min after application of the drug. Rhythmic disorders preceding therapy are 
removed. Headache is established only in two patients with accompanying ischemic heart di­
sease. The lowest relative share of favourably influenced patients is in the group of inhalatory 
corticosteroid treatment. Probably, it is determined by the circumstance that the majority of 
these patients are corticosteroid-dependent and with considerably manifested durable bronchial 
obstruction, Corticosteroid dependence is eliminated n̂ 7 of the patients of this group. Patients 
treated with Intal or Zaditen are also favourably influenced. Most frequently, Intal induces a 
very good therapeutic effect while Zaditen results in a goodt>ne. Ten patients of this group be-
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come spastic during the 3-month follow-up. This circumstance can be due to the fact that des­
pite of phosphodiesterase inhibitory effect of th*se preparations they do not possess a strong 
direct bronchorelaxation effect similarly to classic phosphodiesterase inhibitors such as theo-
phyllin preparations (6, 7). Clinical effectiveness of their "prophylactic" usage increases by com­
bination with specific hyp ©sensibilization started in remittent periods when bronchial obstruc­
tion is neutralized. 
The dynamic follow-up reveals differences in clinical effectiveness and spirographs paramet­
ers. While theophyllin preparations and fi-agonists influence on diffuse bronchial obstruction 
(of smaller respiratory tracts, inclusive) objectified by means of capacity measurements with 
smoUer pulmonary volumes cholinolytic medicaments, calcium antagonists and corticosteroids 
for local use influence predominantly on large respiratory tract obstruction (pulmonary resist­
ance). 
We can conclude that as result from our investigations of many years it can be accepted that 
modern combined treatment of bronchoobstructive diseases should comprise as "basic therapy" 
some bronchodilatators - theophyllin preparation (recommended is that one with least side 
effects), Б-mimetics or cholinolytics. When there are cardiovascular contraindications a calcium 
antagonist is preferred but when corticosteroid dependent and hardly influenced patients are 
concerned a corticosteroid preparation for local application should be administered. In the re­
mittent period, combination of bronchodilatators and specific hyposensibilization together 
with prophylactic medicaments — Intal or Zaditen - results in maximally good therapeutic 
effect. 
R E F E R E N C E S 
1. 3 л a T a H о в, 3. , К. К и с ь о в а, М . П е н е в а . Съвр. мед., 1981, № 4, 10-12. - 2. 3 л а т а-
н о в, 3 . , К. К и с ь о в а , М . П е н е в а . Пневмол. и фтизиатр., 1983, № 2, 65-68. - 3. К о м а р о в , 
Ф. И., И. Г. Д а н и л я к. Клин, мед., 1981, № 4, 10-12. - 4. С и л ь в е с т р о в , В. П. Тер. арх., №982, 
№ 4, 3 -9 . - 5 . С т а н е в а - С т о я н о в а , М., Г. К о с т у р к о в . Съвременно лечение на бронхиал­
ната астма. Науч. обзор . София, ЦНИМЗ, 1981. - 6. Ш м е л е в, Е. В., Тер. арх., 1983, № 3, 25-27. -
7, B e r n s t e i n , J . , et aL / . Allergy Clin. Immunol, 68, 1981, No 4, 247-254. - 8. V a 1 v е г d. E . , et 
aL Ann. Allergy, 48, 1982, No 1, 32-35 . - 9. W a g n е г, С., et al. Ann. Allergy, 50, 1983, No 1, 19-22 . 
КОМБИНИРОВАННОЕ ЛЕЧЕНИЕ БРОНХООБСТРУКТИВНЫХ ЗАБОЛЕВАНИЙ 
К. Кисеаа, М. Пенева, 3. Златанов 
Р Е З Ю М Е 
Проведено сравнительное исследование клинической эффективности некоторых современных 
схем лечения бронхообструктивных заболеваний. Больные были распределены на семь групп. В 
каждой группе проводилось лечение с применением одного из препаратов: новфилин, филоконтин 
(теотард), сальбутамол (паргосистен), атровент, бекломед, изоптин, интал (задитен). У всех боль­
ных прослеживались показатели внешнего дыхания и физикального синдрома до и после лечения 
соответствующими препаратами. В результате исследований, проводимых в течение долгих лет, 
авторы делают заключение, что современное комбинированное лечение бронхообструктивных за­
болеваний должно включать в качестве „базисной терапии" препарат теофилина, бетамиметик или 
холинолитик, а при кортизонзависимых больных - бекломед. Наилучший эффект дает сочетание 
бронходилататоркого лечения со специфической гигюсенсибилизацией, которое применяется одно­
временно с медикаментами, имеющими профилактическс е действие - инталом или задитеном. 
